Clinical Trials · NCT01587222
Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Anna Cruceta
- Enrollment
- 0
- Start date
- Jul 2016
- Locations
- 1 site, Spain
- Primary endpoint
- Glomerular filtration